Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Psychiatry ; 26(2): 534-544, 2021 02.
Article in English | MEDLINE | ID: mdl-30504824

ABSTRACT

Benzodiazepines (BZDs) have been a standard treatment for anxiety disorders for decades, but the neuronal circuit interactions mediating their anxiolytic effect remain largely unknown. Here, we find that systemic BZDs modulate central amygdala (CEA) microcircuit activity to gate amygdala output. Combining connectome data with immediate early gene (IEG) activation maps, we identified the CEA as a primary site for diazepam (DZP) anxiolytic action. Deep brain calcium imaging revealed that brain-wide DZP interactions shifted neuronal activity in CEA microcircuits. Chemogenetic silencing showed that PKCδ+/SST- neurons in the lateral CEA (CEAl) are necessary and sufficient to induce the DZP anxiolytic effect. We propose that BZDs block the relay of aversive signals through the CEA, in part by local binding to CEAl SST+/PKCδ- neurons and reshaping intra-CEA circuit dynamics. This work delineates a strategy to identify biomedically relevant circuit interactions of clinical drugs and highlights the critical role for CEA circuitry in the pathophysiology of anxiety.


Subject(s)
Anti-Anxiety Agents , Central Amygdaloid Nucleus , Anti-Anxiety Agents/pharmacology , Anxiety/drug therapy , Benzodiazepines/pharmacology , Diazepam
2.
Mol Psychiatry ; 25(2): 428-441, 2020 02.
Article in English | MEDLINE | ID: mdl-29904149

ABSTRACT

Survival relies on optimizing behavioral responses through experience. Animals often react to acute stress by switching to passive behavioral responses when coping with environmental challenge. Despite recent advances in dissecting mammalian circuitry for Pavlovian fear, the neuronal basis underlying this form of non-Pavlovian anxiety-related behavioral plasticity remains poorly understood. Here, we report that aversive experience recruits the posterior paraventricular thalamus (PVT) and corticotropin-releasing hormone (CRH) and sensitizes a Pavlovian fear circuit to promote passive responding. Site-specific lesions and optogenetic manipulations reveal that PVT-to-central amygdala (CE) projections activate anxiogenic neuronal populations in the CE that release local CRH in response to acute stress. CRH potentiates basolateral (BLA)-CE connectivity and antagonizes inhibitory gating of CE output, a mechanism linked to Pavlovian fear, to facilitate the switch from active to passive behavior. Thus, PVT-amygdala fear circuitry uses inhibitory gating in the CE as a shared dynamic motif, but relies on different cellular mechanisms (postsynaptic long-term potentiation vs. presynaptic facilitation), to multiplex active/passive response bias in Pavlovian and non-Pavlovian behavioral plasticity. These results establish a framework promoting stress-induced passive responding, which might contribute to passive emotional coping seen in human fear- and anxiety-related disorders.


Subject(s)
Corticotropin-Releasing Hormone/metabolism , Fear/physiology , Stress, Psychological/metabolism , Adaptation, Psychological/physiology , Affect , Amygdala/metabolism , Animals , Anxiety/metabolism , Anxiety Disorders/metabolism , Central Amygdaloid Nucleus/metabolism , Emotions/physiology , Humans , Long-Term Potentiation , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Midline Thalamic Nuclei/physiopathology , Neurons/metabolism , Thalamus/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...